Sulfateq BV is an innovative privately-held biotechnology company that is developing breakthrough compounds for the treatment of a wide range of therapeutic indications related to mitochondrial dysfunction. Our compound library emerged from research on natures natural mechanisms to cope with mitochondrial stress, including hibernation. SUL compounds have an unique mechanism-of-action and the potential to revolutionize the standard-of-care of diseases associated with a declined mitochondrial function.
Looking for a particular Sulfateq B.V. employee's phone or email?
The Sulfateq B.V. annual revenue was $5.7 million in 2026.
Daniël Swart is the Chief of Operations of Sulfateq B.V..
3 people are employed at Sulfateq B.V..
Sulfateq B.V. is based in Groningen, Groningen.
The NAICS codes for Sulfateq B.V. are [5417, 541, 541713, 54171, 54].
The SIC codes for Sulfateq B.V. are [87, 873].